There is a substantial variation in the use of prophylactic G-CSF during dose-dense paclitaxel in clinical practice.

Reasons for omitting prophylactic G-CSF during DD-T included high baseline absolute neutrophil count and pain.

The omission of prophylactic G-CSF during dose-dense paclitaxel was not associated with treatment delay or adverse events.